Oxidative stress signaling in Alzheimer's disease.
暂无分享,去创建一个
G. Perry | M. Smith | A. Nunomura | P. Moreira | B. Su | X. Wang | H-g Lee | X. Zhu | M A Smith | X Zhu | G Perry | A Nunomura | P I Moreira | B Su | X Wang | H-gon Lee | George Perry | M. Smith | M. Smith
[1] G. Perry,et al. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. , 1994, The American journal of pathology.
[2] Yan‐Mei Li,et al. Hydrogen peroxide can be generated by tau in the presence of Cu(II). , 2007, Biochemical and biophysical research communications.
[3] N. Robakis,et al. Immunohistochemical evidence of antioxidant stress in Alzheimer's disease , 1992 .
[4] J. Baynes. Role of Oxidative Stress in Development of Complications in Diabetes , 1991, Diabetes.
[5] Xiongwei Zhu,et al. Apoptosis in Alzheimer disease: a mathematical improbability. , 2006, Current Alzheimer research.
[6] R. Swerdlow,et al. Mitochondrial abnormalities in cybrid cell models of sporadic Alzheimer's disease worsen with passage in culture , 2004, Neurobiology of Disease.
[7] Xiantao Wang,et al. Signaling Events in Amyloid β-Peptide-induced Neuronal Death and Insulin-like Growth Factor I Protection* , 2002, The Journal of Biological Chemistry.
[8] I. Ferrer,et al. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies , 2001, Journal of Neural Transmission.
[9] Virginia M. Y. Lee,et al. Increased Lipid Peroxidation Precedes Amyloid Plaque Formation in an Animal Model of Alzheimer Amyloidosis , 2001, The Journal of Neuroscience.
[10] R. Swerdlow,et al. Abnormal Mitochondrial Morphology in Sporadic Parkinson's and Alzheimer's Disease Cybrid Cell Lines , 2000, Experimental Neurology.
[11] George Perry,et al. Role of mitochondrial dysfunction in Alzheimer's disease , 2002, Journal of neuroscience research.
[12] P. Ince,et al. Mitochondrial enzyme-deficient hippocampal neurons and choroidal cells in AD , 2001, Neurology.
[13] Xiongwei Zhu,et al. Activation and redistribution of c‐Jun N‐terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease , 2001, Journal of neurochemistry.
[14] Hyoung-Gon Lee,et al. Challenging the Amyloid Cascade Hypothesis: Senile Plaques and Amyloid‐β as Protective Adaptations to Alzheimer Disease , 2004, Annals of the New York Academy of Sciences.
[15] W. Markesbery,et al. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[16] M. Beal,et al. Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[17] W. D. Ehmann,et al. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease , 1995, Neurology.
[18] P. Riederer,et al. Alzheimer's disease – synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts , 1998, Journal of Neural Transmission.
[19] S. Hazen,et al. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. , 1999, The Journal of clinical investigation.
[20] J. Zweier,et al. Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide , 1995, Nature Medicine.
[21] D. Harman,et al. The aging process. , 1981, Basic life sciences.
[22] C. Behl,et al. Hydrogen peroxide mediates amyloid β protein toxicity , 1994, Cell.
[23] A. Nunomura,et al. Oxidative Damage Is the Earliest Event in Alzheimer Disease , 2001, Journal of neuropathology and experimental neurology.
[24] X. Chen,et al. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease , 1996, Nature.
[25] T. Arendt,et al. Aberrant expression of NOS isoforms in Alzheimer’s disease is structurally related to nitrotyrosine formation , 2002, Brain Research.
[26] Xudong Huang,et al. Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2). , 2002, The Journal of biological chemistry.
[27] Y. Surh,et al. β‐Amyloid Induces Oxidative DNA Damage and Cell Death through Activation of c‐Jun N Terminal Kinase , 2002 .
[28] Robert B. Petersen,et al. Mitochondrial abnormalities in Alzheimer disease , 2000, Neurobiology of Aging.
[29] George Perry,et al. Activation of p38 Kinase Links Tau Phosphorylation, Oxidative Stress, and Cell Cycle‐Related Events in Alzheimer Disease , 2000 .
[30] R. Veerhuis,et al. The role of complement and activated microglia in the pathogenesis of Alzheimer's disease , 1996, Neurobiology of Aging.
[31] W. Markesbery,et al. p38 Kinase Is Activated in the Alzheimer's Disease Brain , 1999, Journal of neurochemistry.
[32] George Perry,et al. Physiological regulation of tau phosphorylation during hibernation , 2008, Journal of neurochemistry.
[33] M. Soriani,et al. Antioxidant potential of anaerobic human plasma: role of serum albumin and thiols as scavengers of carbon radicals. , 1994, Archives of biochemistry and biophysics.
[34] W. Markesbery,et al. The Nitration Product 5-Nitro-γ-tocopherol Is Increased in the Alzheimer Brain , 2002 .
[35] Huaxi Xu,et al. Phosphorylation of tau antagonizes apoptosis by stabilizing β-catenin, a mechanism involved in Alzheimer's neurodegeneration , 2007, Proceedings of the National Academy of Sciences.
[36] A. Palmer,et al. Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease , 1994, Brain Research.
[37] I. Kanazawa,et al. JNK activation is associated with intracellular β-amyloid accumulation , 2000 .
[38] H. Möller,et al. A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients , 2000, Neurobiology of Aging.
[39] M. Beal,et al. Cytochemical Demonstration of Oxidative Damage in Alzheimer Disease by Immunochemical Enhancement of the Carbonyl Reaction with 2,4-Dinitrophenylhydrazine , 1998, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[40] Joseph S. Beckman,et al. Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease , 1997, The Journal of Neuroscience.
[41] C. Velez-Pardo,et al. Aβ[25–35] Peptide and Iron Promote Apoptosis in Lymphocytes by an Oxidative Stress Mechanism: Involvement of H2O2, Caspase-3, NF-κB, p53 and c-Jun , 2002 .
[42] M. Smith,et al. Is increased redox-active iron in Alzheimer disease a failure of the copper-binding protein ceruloplasmin? , 1999, Free radical biology & medicine.
[43] R. Veerhuis,et al. Amyloid β Protein Primes Cultured Rat Microglial Cells for an Enhanced Phorbol 12‐Myristate 13‐Acetate‐Induced Respiratory Burst Activity , 1996, Journal of neurochemistry.
[44] Xiongwei Zhu,et al. Alzheimer disease: evidence for a central pathogenic role of iron-mediated reactive oxygen species. , 2004, Journal of Alzheimer's disease : JAD.
[45] C. Plata-salamán,et al. Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.
[46] Xiongwei Zhu,et al. Ribosomal RNA in Alzheimer Disease Is Oxidized by Bound Redox-active Iron* , 2005, Journal of Biological Chemistry.
[47] George Perry,et al. RNA Oxidation Is a Prominent Feature of Vulnerable Neurons in Alzheimer’s Disease , 1999, The Journal of Neuroscience.
[48] W. Blackstock,et al. Phosphorylation Sites on Tau Identified by Nanoelectrospray Mass Spectrometry , 2000, Journal of neurochemistry.
[49] G. Perry,et al. Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease. , 2000, Antioxidants & redox signaling.
[50] D. Perl,et al. Evidence of neuronal oxidative damage in Alzheimer's disease. , 1996, The American journal of pathology.
[51] P. Mcgeer,et al. β‐Amyloid protein enhances macrophage production of oxygen free radicals and glutamate , 1997 .
[52] Ying-Hua Liu,et al. Peroxynitrite induces Alzheimer‐like tau modifications and accumulation in rat brain and its underlying mechanisms , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[53] D. Galati,et al. Accumulation of Amyloid Precursor Protein in the Mitochondrial Import Channels of Human Alzheimer’s Disease Brain Is Associated with Mitochondrial Dysfunction , 2006, The Journal of Neuroscience.
[54] P. Hof,et al. Cell-Cycle Reentry and Cell Death in Transgenic Mice Expressing Nonmutant Human Tau Isoforms , 2005, The Journal of Neuroscience.
[55] L. Greene,et al. β‐Amyloid‐induced neuronal apoptosis requires c‐Jun N‐terminal kinase activation , 2001, Journal of neurochemistry.
[56] A. Kontush,et al. Amyloid-β: an antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer’s disease , 2001 .
[57] D. Butterfield,et al. Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. , 2000, Journal of structural biology.
[58] B. P. Yu,et al. Cellular defenses against damage from reactive oxygen species. , 1994, Physiological reviews.
[59] B. Winblad,et al. Acute anoxia induces tau dephosphorylation in rat brain slices and its possible underlying mechanisms , 2005, Journal of neurochemistry.
[60] L. Iversen,et al. The toxicity in vitro of beta-amyloid protein. , 1995, The Biochemical journal.
[61] S. Bondy,et al. Promotion of transition metal-induced reactive oxygen species formation by β-amyloid , 1998, Brain Research.
[62] D. Butterfield,et al. Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. , 2001, Trends in molecular medicine.
[63] Xudong Huang,et al. The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. , 1999, Biochemistry.
[64] S Shimohama,et al. Activation of MKK6, an upstream activator of p38, in Alzheimer's disease , 2001, Journal of neurochemistry.
[65] J. Quinn,et al. Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease. , 2004, Human molecular genetics.
[66] Mark A. Smith,et al. Advanced Maillard Reaction End Products, Free Radicals, and Protein Oxidation in Alzheimer's Disease a , 1994, Annals of the New York Academy of Sciences.
[67] D. Butterfield,et al. Alzheimer’s amyloid β-peptide (1–42): involvement of methionine residue 35 in the oxidative stress and neurotoxicity properties of this peptide , 2004, Neurobiology of Aging.
[68] J. Crowley,et al. The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation. , 1999, The Journal of clinical investigation.
[69] M. Beal,et al. Oxidative damage in Alzheimer's , 1996, Nature.
[70] P. Lewitt,et al. Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders , 1996, Brain Research.
[71] J. Thome,et al. Advanced glycation endproducts-associated parameters in the peripheral blood of patients with Alzheimer's disease. , 1996, Life sciences.
[72] D. Bozyczko‐Coyne,et al. CEP‐1347/KT‐7515, an inhibitor of SAPK/JNK pathway activation, promotes survival and blocks multiple events associated with Aβ‐induced cortical neuron apoptosis , 2001, Journal of neurochemistry.
[73] Mark A. Smith,et al. 4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's Disease , 1997, Journal of neurochemistry.
[74] M. Mattson,et al. A Role for 4‐Hydroxynonenal, an Aldehydic Product of Lipid Peroxidation, in Disruption of Ion Homeostasis and Neuronal Death Induced by Amyloid β‐Peptide , 1997, Journal of neurochemistry.
[75] J. Quinn,et al. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. , 2006, Human molecular genetics.
[76] J. Thome,et al. Advanced glycation endproducts in ageing and Alzheimer's disease , 1997, Brain Research Reviews.
[77] S. Tsuji,et al. Apolipoprotein E allele–dependent antioxidant activity in brains with Alzheimer’s disease , 2000, Neurology.
[78] H. Qing,et al. Oxidative stress potentiates BACE1 gene expression and Aβ generation , 2005, Journal of Neural Transmission.
[79] Jack C. de la Torre,et al. Cerebromicrovascular Pathology in Alzheimer’s Disease Compared to Normal Aging , 1997 .
[80] B. Anderton,et al. Stress‐Activated Protein Kinase/c‐Jun N‐Terminal Kinase Phosphorylates τ Protein , 1997, Journal of neurochemistry.
[81] R. Mahley,et al. Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[82] J. Blass,et al. Abnormalities of mitochondrial enzymes in Alzheimer disease , 1998, Journal of Neural Transmission.
[83] R J Mark,et al. Amyloid β-Peptide Impairs Glucose Transport in Hippocampal and Cortical Neurons: Involvement of Membrane Lipid Peroxidation , 1997, The Journal of Neuroscience.
[84] J. D. Robertson,et al. Copper, iron and zinc in Alzheimer's disease senile plaques , 1998, Journal of the Neurological Sciences.
[85] J. Joseph,et al. The state versus amyloid-β: the trial of the most wanted criminal in Alzheimer disease , 2002, Peptides.
[86] G. Perry,et al. β‐Site APP cleaving enzyme up‐regulation induced by 4‐hydroxynonenal is mediated by stress‐activated protein kinases pathways , 2005, Journal of neurochemistry.
[87] B. Ghetti,et al. Activation of the JNK/p38 Pathway Occurs in Diseases Characterized by Tau Protein Pathology and Is Related to Tau Phosphorylation But Not to Apoptosis , 2001, Journal of neuropathology and experimental neurology.
[88] C. Colaco,et al. A glycation connection , 1994, Nature.
[89] Visith Thongboonkerd,et al. Proteomic identification of nitrated proteins in Alzheimer's disease brain , 2003, Journal of neurochemistry.
[90] A. Nebreda,et al. Reactivating Kinase/p38 Phosphorylates τ Protein In Vitro , 1997 .
[91] Fahmeed Hyder,et al. Energetic basis of brain activity: implications for neuroimaging , 2004, Trends in Neurosciences.
[92] Xiongwei Zhu,et al. Mitochondrial failures in Alzheimer's disease , 2004, American journal of Alzheimer's disease and other dementias.
[93] Xiongwei Zhu,et al. Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the ‘two hit’ hypothesis , 2001, Mechanisms of Ageing and Development.
[94] M. Wajner,et al. Impairment of energy metabolism in hippocampus of rats subjected to chemically-induced hyperhomocysteinemia. , 2003, Biochimica et biophysica acta.
[95] D. Schubert,et al. The role of iron in beta amyloid toxicity. , 1995, Biochemical and biophysical research communications.
[96] C. W. Scott,et al. Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[97] B. Hyman,et al. Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function , 2005, Science.
[98] M. Mattson,et al. Oxidative stress activates a positive feedback between the γ‐ and β‐secretase cleavages of the β‐amyloid precursor protein , 2007 .
[99] H. Reichmann,et al. Electron transport chain defects in Alzheimer's disease. , 1994, Neurology.
[100] M. Smith,et al. Neuronal RNA Oxidation in Alzheimer's Disease and Down's Syndrome , 1999, Annals of the New York Academy of Sciences.
[101] P. Lantos,et al. Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease. , 1999, Journal of neuropathology and experimental neurology.
[102] J. Loike,et al. Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils , 1996, Nature.
[103] S. Rapoport,et al. Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease. , 1994, Brain research. Molecular brain research.
[104] Ashley I. Bush,et al. Redox-active iron mediates amyloid-β toxicity , 2001 .
[105] B. Frei,et al. Physiological thiol compounds exert pro- and anti-oxidant effects, respectively, on iron- and copper-dependent oxidation of human low-density lipoprotein. , 1997, Biochimica et biophysica acta.
[106] M. Greenberg,et al. β-Amyloid Induces Neuronal Apoptosis Via a Mechanism that Involves the c-Jun N-Terminal Kinase Pathway and the Induction of Fas Ligand , 2001, The Journal of Neuroscience.
[107] E. Masliah,et al. Myeloperoxidase Polymorphism Is Associated with Gender Specific Risk for Alzheimer's Disease , 1999, Experimental Neurology.
[108] M. Esiri,et al. Mitochondrial enzyme expression in the hippocampus in relation to Alzheimer-type pathology , 1999, Acta Neuropathologica.
[109] S. Arlt,et al. Amyloid-β is an antioxidant for lipoproteins in cerebrospinal fluid and plasma , 2001 .
[110] G. Perry,et al. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[111] Xiongwei Zhu,et al. JKK1, an upstream activator of JNK/SAPK, is activated in Alzheimer's disease , 2003, Journal of neurochemistry.
[112] R. Mrak,et al. Correlation of Astrocytic S100β Expression with Dystrophic Neurites in Amyloid Plaques of Alzheimer's Disease , 1996, Journal of neuropathology and experimental neurology.
[113] M. Goldberg,et al. Amyloid-β Peptides Are Cytotoxic to Oligodendrocytes , 2001, The Journal of Neuroscience.
[114] M. Beal,et al. Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. , 2008, Trends in molecular medicine.
[115] W. Markesbery,et al. Four-Hydroxynonenal, a Product of Lipid Peroxidation, is Increased in the Brain in Alzheimer’s Disease , 1998, Neurobiology of Aging.
[116] Philip R. Cohen,et al. Phosphorylation of microtubule‐associated protein tau by stress‐activated protein kinases , 1997, FEBS letters.
[117] Hyoung-Gon Lee,et al. Tau phosphorylation in Alzheimer's disease: pathogen or protector? , 2005, Trends in molecular medicine.
[118] G. Perry,et al. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[119] Jason P. Sheehan,et al. Calcium Homeostasis and Reactive Oxygen Species Production in Cells Transformed by Mitochondria from Individuals with Sporadic Alzheimer’s Disease , 1997, The Journal of Neuroscience.
[120] L. Mucke,et al. Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[121] H. Braak,et al. Localization of active forms of C-jun kinase (JNK) and p38 kinase in Alzheimer's disease brains at different stages of neurofibrillary degeneration. , 2001, Journal of Alzheimer's disease : JAD.
[122] Xiongwei Zhu,et al. c‐Jun phosphorylation in Alzheimer disease , 2007, Journal of neuroscience research.
[123] Mark A. Smith,et al. Carbonyl‐Related Posttranslational Modification of Neurofilament Protein in the Neurofibrillary Pathology of Alzheimer's Disease , 1995, Journal of neurochemistry.
[124] R. Mason,et al. Alzheimer's disease amyloid beta peptide 25-35 inhibits lipid peroxidation as a result of its membrane interactions. , 1997, Biochemical and biophysical research communications.
[125] Xi Chen,et al. Materials and Methods Som Text Figs. S1 and S2 Table S1 References Abad Directly Links A to Mitochondrial Toxicity in Alzheimer's Disease , 2022 .
[126] D. Flood,et al. Activation of c-Jun N-Terminal Kinase and p38 in an Alzheimer's Disease Model Is Associated with Amyloid Deposition , 2002, The Journal of Neuroscience.
[127] Sudha Seshadri,et al. Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease , 2002 .
[128] G. Perry,et al. Involvement of maillard reactions in Alzheimer disease , 2009, Neurotoxicity Research.
[129] R N Kalaria,et al. Induction of Heme Oxygenase‐1 mRNA and Protein in Neocortex and Cerebral Vessels in Alzheimer's Disease , 1995, Journal of neurochemistry.
[130] C. Filley,et al. Reduced platelet cytochrome c oxidase activity in Alzheimer's disease , 1994, Neurology.
[131] M. Staufenbiel,et al. Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer’s disease, in APP23 transgenic mice and after experimental brain lesion in rat: evidence for an induction by amyloid pathology , 2001, Brain Research.
[132] G. Perry,et al. Neuronal Oxidative Stress Precedes Amyloid‐β Deposition in Down Syndrome , 2000 .